THE DISTRIBUTION OF RADIOACTIVE IODINE IN HUMAN TISSUES: NECROPSY STUDY IN NINE PATIENTS*

J. B. Trunnell, Benedict J. Duffy, John T. Godwin, Wendell C. Peacock, LORRAINE KIRSCHNER, Ruth F. Hill

The Journal of Clinical Endocrinology & Metabolism · 1950 · 42 citations · 0 references

Concepts

Abstract

FROM the inception of therapy with radioactive iodine there has been adequate reason to fear that tissues other than thyroid or thyroid cancer might be subjected to damaging quantities of radiation. Our own experiences (1) have in fact indicated that at least the blood-forming organs and female gonads may be seriously injured during treatment of metastatic thyroid cancer with I131. Even though therapy of cancer of the thyroid with I131 remains a relatively uncommon procedure, treatment of hyperthyroidism with this substance is on an ever-increasing scale. We may expect constantly to be confronted therefore with the question of damage to non-“target” tissues. Until recently, predictability of injury had perforce to be based upon chemically determined iodine distribution data of unknown validity (2). These older data indicated that the pituitary, adrenals, parathyroids, and gonads might be expected to concentrate sufficiently more iodine than other tissues and therefore might be more easily damaged by radioactive iodine.